C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2011
03/17/2011	US20110065148 Peptides and uses thereof
03/17/2011	US20110065147 Methods and reagents for modulating cholesterol levels
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065142 Sebocytes, sebocyte-cell line and uses thereof
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065131 Assays for mutagenesis detection
03/17/2011	US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
03/17/2011	US20110065123 Methods for diagnosis of Clostridium difficile and methods and vectors for recombinant toxin expression
03/17/2011	US20110065122 Method for accessing microbial diversity
03/17/2011	US20110065121 Method for the detection of apoptosis
03/17/2011	US20110065118 Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
03/17/2011	US20110065117 Mesothelioma Specific Transferred Promoter And Use Thereof
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110065106 Recombinase polymerase amplification
03/17/2011	US20110065103 Use of rna for reprogramming somatic cells
03/17/2011	US20110065092 Use of nonviable particles comprising an internal control (ic) nucleic acid
03/17/2011	US20110065089 Novel strain of sars-associated coronavirus and applications thereof
03/17/2011	US20110064797 Capsule of thermogenic cells for treating a metabolic disease
03/17/2011	US20110064792 Method for Opening Tight Junctions
03/17/2011	US20110064768 Immunogenic Compositions
03/17/2011	US20110064763 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
03/17/2011	US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
03/17/2011	US20110064758 Infectious clones of torque teno virus
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064756 Novel sequences of brachyspira, immunogenic compounds, methods for preparation and use thereof
03/17/2011	US20110064751 Targeted immunoconjugates
03/17/2011	US20110064734 Prevention and treatment of amyloidogenic disease
03/17/2011	US20110064733 Ca6 antigen-specific cytotoxic conjugate and methods of using the same
03/17/2011	US20110064726 ANTI IgE ANTIBODIES
03/17/2011	US20110064725 High affinity, anti-human ige antibodies
03/17/2011	US20110064717 Homing endonuclease genes and their targets
03/17/2011	US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use
03/17/2011	US20110064651 Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies
03/17/2011	DE112008003237T5 Promotoren von Brassica napus für samenspezifische Genexpression Promoters of Brassica napus for seed-specific gene expression
03/17/2011	DE102009032645B3 Mikroröhren, umfassend Bestandteile der äußeren Membran von E. coli Zellen und rekombinant exprimierte S-Layer-Proteine, Verfahren zu ihrer Herstellung und Verwendung Microtubes, comprising constituents of the outer membrane of E. coli cells and recombinantly expressed S-layer proteins, processes for their preparation and use
03/17/2011	DE102005059217B4 Verfahren und Testkit zur Trennung, Aufreinigung und Wiedergewinnung von lang- und kurzkettigen Nukleinsäuren Method and kit for separation, purification and recovery of long- and short-chain nucleic acids
03/17/2011	DE102005041616B4 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and coding for these polynucleotides and uses thereof
03/17/2011	CA2773983A1 Mutant sodium channel nav1.7 and methods related thereto
03/17/2011	CA2773886A1 Modulation of huntingtin expression
03/17/2011	CA2773694A1 Microorganisms and methods for the co-production of isopropanol with primary alcohols, diols and acids
03/17/2011	CA2773664A1 Composition for treatment of cxcl8-mediated lung inflammation
03/17/2011	CA2773624A1 Composition and method for imaging stem cells
03/17/2011	CA2773424A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
03/17/2011	CA2773320A1 Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
03/17/2011	CA2773281A1 Method
03/17/2011	CA2772400A1 A novel protein delivery system to generate induced pluripotent stem (ips) cells or tissue-specific cells
03/17/2011	CA2772352A1 Compositions for inhibiting gene expression and uses thereof
03/17/2011	CA2771863A1 Compositions that induce t cell help
03/17/2011	CA2771771A1 Porcine torque teno virus vaccines and diagnosis
03/17/2011	CA2771172A1 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
03/17/2011	CA2714790A1 Wheat plants with immunity to wsmv
03/16/2011	EP2295988A2 Multiplexed molecular analysis apparatus and its fabrication method
03/16/2011	EP2295971A2 Conjugate probes and optical detection of analytes
03/16/2011	EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
03/16/2011	EP2295605A1 Method of classifying gene expression strength in lung cancer tissues
03/16/2011	EP2295604A2 Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
03/16/2011	EP2295603A1 Method and devices for multiplexing amplification reactions
03/16/2011	EP2295600A1 Method and test strip for detecting sensitivity to isoniazid in mycobacterium tuberculosis
03/16/2011	EP2295599A1 Method for detection of idiopathic interstitial pneumonia
03/16/2011	EP2295598A1 Method and kit for detection of cancer, and therapeutic agent for cancer
03/16/2011	EP2295596A1 A method and kit for purification of recombinant proteins using a self-cleaving ptotein intein
03/16/2011	EP2295593A1 Method for the enymatic production of 3-hydroxy-3-methylbutyric acid from acetone and acetyl-CoA
03/16/2011	EP2295591A1 Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses
03/16/2011	EP2295590A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle
03/16/2011	EP2295589A1 Improved expression elements
03/16/2011	EP2295588A1 Novel artificial antigen presenting cells and uses thefor
03/16/2011	EP2295587A1 Herbicide tolerant cotton plants and methods for identifying same
03/16/2011	EP2295586A2 Plant centromere compositions
03/16/2011	EP2295585A1 Nucleotide sequences mediating plant male fertility and method of using same
03/16/2011	EP2295584A2 Transgenic plant-based methods for plant pests using RNAi
03/16/2011	EP2295583A2 Method of plastid transformation in Asteraceae, vector for use therein and plants thus obtained
03/16/2011	EP2295582A2 Genes and uses for plant improvement
03/16/2011	EP2295581A2 Morphological mutants of filamentous fungi
03/16/2011	EP2295580A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
03/16/2011	EP2295579A2 Novel peptide-forming enzyme gene
03/16/2011	EP2295578A2 Cyp1b1 nucleic acids and methods of use
03/16/2011	EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof
03/16/2011	EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof
03/16/2011	EP2295575A2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
03/16/2011	EP2295574A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295573A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295572A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295571A1 Method of diagnosing small cell lung cancer
03/16/2011	EP2295570A1 Method of diagnosing small cell lung cancer
03/16/2011	EP2295569A1 Methods and compositions for preparing rna from a fixed sample
03/16/2011	EP2295568A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions
03/16/2011	EP2295567A2 Compositions and methods for using a solid support to purify DNA
03/16/2011	EP2295566A1 Method of producing D-serine by using a microbial D-serine synthase.
03/16/2011	EP2295565A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell
03/16/2011	EP2295564A1 Composition and method for determination of esophageal cancer
03/16/2011	EP2295563A1 B-amylase, gene coding therefor and manufacturing method thereof
03/16/2011	EP2295562A2 Method for producing sterility-derived genetically modified grasses
03/16/2011	EP2295561A2 Gene group applicable to cancer prognostication
03/16/2011	EP2295560A1 Directed evolution of arginine deiminase for increased activity at physiological pH
03/16/2011	EP2295559A1 Novel variant hyprocrea jecorina CBH1 cellulases
03/16/2011	EP2295558A1 Xylanase variants
03/16/2011	EP2295553A1 Phytase variants
03/16/2011	EP2295551A1 Thermostable reverse transcriptases and uses thereof

1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 4023